Related Experiment Video
Updated: May 22, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Treatment with anti-inflammatory drugs in community-acquired pneumonia
S C A Meijvis1, E M W van de Garde, G T Rijkers
1Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands. s.meijvis@antoniusziekenhuis.nl
Abstract:
Pneumonia exhibits a broad range of severity, from mildly symptomatic at one end to fulminant septic shock and death at the other. Although an adequate inflammatory response is necessary for the clearance of microorganisms, excessive inflammation can lead to ongoing local and systemic damage. Because of this extended inflammatory response despite appropriate antibiotic therapy, as well as increasing antibiotic resistance, adjuvant therapy for pneumonia that can favourably modify the immune response has become an increasingly relevant approach to improve prognosis. Different adjuvant treatment options for pneumonia have recently been proposed. Promising treatment options include corticosteroids, statins, macrolides and Toll-like receptor antagonists. The aim of this review is to summarize the inflammatory response during pneumonia and discuss the current knowledge and future perspectives regarding the anti-inflammatory treatment options for patients with pneumonia.
Insights
Pneumonia
Area of Science:
- Medical Science
- Immunology
- Pharmacology
Background:
- Pneumonia presents with variable severity, from mild symptoms to fatal septic shock.
- Excessive inflammation, despite antibiotics, causes damage and contributes to poor outcomes.
- Rising antibiotic resistance necessitates novel therapeutic strategies.
Purpose of the Study:
- To review the inflammatory processes in pneumonia.
- To discuss current and future anti-inflammatory adjuvant therapies for pneumonia.
Main Methods:
- Literature review of inflammatory responses in pneumonia.
- Analysis of proposed adjuvant treatments including corticosteroids, statins, macrolides, and Toll-like receptor antagonists.
Main Results:
- Excessive inflammation is a key factor in pneumonia severity and complications.
- Several adjuvant therapies show promise in modulating the immune response.
Conclusions:
- Adjuvant anti-inflammatory therapy is crucial for improving pneumonia prognosis.
- Corticosteroids, statins, macrolides, and TLR antagonists are potential future treatments.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Acute Pyelonephritis II: Diagnostic Studies and Management